Immunology News and Research

Latest Immunology News and Research

Scientists discover a new drug-resistance mechanism in breast cancer

Scientists from Università Cattolica in Rome, together with colleagues from the IIGM Foundation (part of Candiolo Institute at Turin), have discovered a new drug-resistance mechanism in breast cancer that leads to the formation of cancer stem cells, (the cells that feed the tumor and cause relapse and metastasis).

6 Oct 2022

Targeted cognitive behavioral therapy can reduce food allergy-related anxiety for children and parents

Children with food allergies, along with their parents, often experience heightened anxiety over risks of casual contact with food allergens.

4 Oct 2022

Immune cell defect tied to the risk of developing rare bacterial infection

Everyone breathes in Mycobacterium avium complex (MAC) bacteria from time to time, but most people don't get sick.

3 Oct 2022

Fungal involvement in tumors may drive worse cancer outcomes

The presence of some fungal species in tumors predicts-;and may even help drive-;worse cancer outcomes, according to a study from Weill Cornell Medicine and Duke University researchers.

3 Oct 2022

Study provides new insights into the underlying physiology of mevalonate kinase deficiency

A new study from the Garvan Institute of Medical Research shows how rises in core body temperature may trigger the inflammatory flares in people with a rare genetic autoinflammatory disease.

3 Oct 2022

Novel peanut-specific human IgE monoclonal antibodies may uncover new therapeutic targets for peanut allergy

A recent Frontiers in Immunology journal study by University of North Carolina at Chapel Hill and Vanderbilt University researchers has created an in vitro system to determine potential therapeutics targeting sensitized effector cells based on human, allergen-specific, Immunoglobulin E (IgE) monoclonal antibodies (mAbs).

2 Oct 2022

Broadly neutralizing antibodies are the blueprint for variant-proof, pansarbecovirus vaccines

A recent Nature Reviews Immunology study has summarized the efficacy of neutralizing antibodies that target four main regions of the spike (S) protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), namely, the receptor-binding domain (RBD) in the S1 subunit, the fusion peptide region in the S2 subunit, the stem helix region, and the N-terminal domain.

2 Oct 2022

The sexual dimorphisms in the epidemiology and pathophysiology of obesity

Researchers reviewed the sexual dimorphisms in obesity.

30 Sep 2022

Study offers insights into how COVID-19 damages the heart

University of Queensland researchers have discovered how COVID-19 damages the heart, opening the door to future treatments.

29 Sep 2022

Food, vaccines, bacteria, and viruses may all prime our immune system to attack SARS-CoV-2

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the causal agent of the ongoing coronavirus disease 2019 (COVID-19) pandemic, primarily causes mild to moderate upper-respiratory tract illness. However, some individuals with COVID-19 develop severe infections and require hospital admission.

27 Sep 2022

Dietary fiber guar gum limits inflammation and delays the onset of MS symptoms in mice

Diets high in guar gum, a common food additive and dietary fiber, limited inflammation and delayed the onset of multiple sclerosis (MS) symptoms in mice, according to new research by members of the University of British Columbia Microbiology and Immunology department.

27 Sep 2022

Leducq Foundation awards $15 million to advance the understanding of atherosclerosis

The Leducq Foundation has awarded $15 million to researchers at UVA Health and their collaborators to advance our understanding of atherosclerosis, or hardening of the arteries, and find better ways to treat it. Diseases linked to atherosclerosis are the leading cause of death in the United States.

27 Sep 2022

Designing a new treatment to treat migraine effectively

In this interview, we speak to Mudra Kapoor, Vice President of Global Medical Affairs for Neuroscience at AbbVie, about atogepant, their new treatment option for migraine.

From AbbVie 26 Sep 2022

Research reveals how carp virus uses a protein domain to inhibit host cell’s defense mechanisms

The team of Prof. Alain Vanderplasschen, virologist and immunologist at the University of Liège, has published an article in the journal Nucleic Acids Research, reporting ten years of research on how a carp virus has been using a protein domain called Zalpha (Zα) to inhibit the defense mechanisms of the host cell.

23 Sep 2022

Generating a mutation in key molecules could offer new way to prevent and treat gonorrhea

Creating a mutation that inhibits how the bacterial pathogen Neisseria gonorrhoeae causes gonorrhea, a common sexually transmitted infection, could offer a new way to prevent and treat the disease, according to researchers in the Institute for Biomedical Sciences at Georgia State University.

23 Sep 2022

Study paves the way for new therapies, vaccines that lead to stronger immunity against Covid-19

Why do some people become seriously ill with Covid-19, while others have no symptoms at all? The answer may lie in the proteins our immune system has previously been exposed to.

23 Sep 2022

Vaccine boosters and breakthrough infections provide substantial immunity against COVID-19

Vaccine boosters and breakthrough infections following vaccination both provide a substantial and potentially pandemic-breaking immunity against COVID-19, according to new laboratory research from Oregon Health & Science University.

22 Sep 2022

Salk scientists launch a new Center for Multiomic Human Brain Cell Atlas with $126 million NIH grant

With a five-year, $126 million grant from the National Institutes of Health, a team led by Salk Institute scientists has launched a new Center for Multiomic Human Brain Cell Atlas.

22 Sep 2022

New board members bring significant leadership experience in the biotech sector

Aspect Biosystems, a biotechnology company pioneering the development of bioprinted tissue therapeutics to transform how we treat disease, is pleased to announce the appointment of three new members to its Board of Directors: Dr. Nancy Krieger, Dr. Don Haut, and Dr. Devyn Smith.

From Aspect Biosystems 22 Sep 2022

Scientists uncover key details of an immune-cell process that underlies excessive inflammation

A team led by Scripps Research scientists has uncovered key details of an immune-cell process that frequently underlies excessive inflammation in the body.

22 Sep 2022

Immunology News and Research

Latest Immunology News and Research

Scientists discover a new drug-resistance mechanism in breast cancer

Targeted cognitive behavioral therapy can reduce food allergy-related anxiety for children and parents

Immune cell defect tied to the risk of developing rare bacterial infection

Fungal involvement in tumors may drive worse cancer outcomes

Study provides new insights into the underlying physiology of mevalonate kinase deficiency

Novel peanut-specific human IgE monoclonal antibodies may uncover new therapeutic targets for peanut allergy

Broadly neutralizing antibodies are the blueprint for variant-proof, pansarbecovirus vaccines

The sexual dimorphisms in the epidemiology and pathophysiology of obesity

Study offers insights into how COVID-19 damages the heart

Food, vaccines, bacteria, and viruses may all prime our immune system to attack SARS-CoV-2

Dietary fiber guar gum limits inflammation and delays the onset of MS symptoms in mice

Leducq Foundation awards $15 million to advance the understanding of atherosclerosis

Designing a new treatment to treat migraine effectively

Research reveals how carp virus uses a protein domain to inhibit host cell’s defense mechanisms

Generating a mutation in key molecules could offer new way to prevent and treat gonorrhea

Study paves the way for new therapies, vaccines that lead to stronger immunity against Covid-19

Vaccine boosters and breakthrough infections provide substantial immunity against COVID-19

Salk scientists launch a new Center for Multiomic Human Brain Cell Atlas with $126 million NIH grant

New board members bring significant leadership experience in the biotech sector

Scientists uncover key details of an immune-cell process that underlies excessive inflammation

Immunology eBook

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration